Novel therapies targeting the myeloma cell and its bone marrow microenvironment

被引:168
作者
Hideshima, T
Chauhan, D
Podar, K
Schlossman, RL
Richardson, P
Anderson, KC
机构
[1] Dana Farber Canc Inst, Jerome Lipper Multiple Myeloma Ctr, Dept Adult Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
关键词
D O I
10.1053/sonc.2001.28608
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:607 / 612
页数:6
相关论文
共 41 条
  • [11] High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment
    Davies, FE
    Rollinson, SJ
    Rawstron, AC
    Roman, E
    Richards, S
    Drayson, M
    Child, JA
    Morgan, GJ
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (15) : 2843 - 2851
  • [12] Proteasome inhibition: A novel mechanism to combat asthma
    Elliott, PJ
    Pien, CS
    McCormack, TA
    Chapman, ID
    Adams, J
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 104 (02) : 294 - 300
  • [13] Feinman R, 1999, BLOOD, V93, P3044
  • [14] PRODUCTION OF LYMPHOTOXIN, A BONE-RESORBING CYTOKINE, BY CULTURED HUMAN MYELOMA CELLS
    GARRETT, IR
    DURIE, BGM
    NEDWIN, GE
    GILLESPIE, A
    BRINGMAN, T
    SABATINI, M
    BERTOLINI, DR
    MUNDY, GR
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (09) : 526 - 532
  • [15] Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade
    Geitz, H
    Handt, S
    Zwingenberger, K
    [J]. IMMUNOPHARMACOLOGY, 1996, 31 (2-3): : 213 - 221
  • [16] GUPTA D, IN PRESS LEUKEMIA
  • [17] Multiple myeloma: Increasing evidence for a multistep transformation process
    Hallek, M
    Bergsagel, PL
    Anderson, KC
    [J]. BLOOD, 1998, 91 (01) : 3 - 21
  • [18] HARBISON MT, 2000, P AM ASSOC CANC RES, V41, P71
  • [19] Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset
    Haslett, PAJ
    Corral, LG
    Albert, M
    Kaplan, G
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (11) : 1885 - 1892
  • [20] Prostate carcinoma cell death resulting from inhibition of proteasome activity is independent of functional Bcl-2 and p53
    Herrmann, JL
    Briones, F
    Brisbay, S
    Logothetis, CJ
    McDonnell, TJ
    [J]. ONCOGENE, 1998, 17 (22) : 2889 - 2899